Stocktoria
MARSH & MCLENNAN COMPANIES, INC. MRSH
MARSH & MCLENNAN COMPANIES, INC. (MRSH) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.09% (safety: moderate). FY2025 revenue was $27.0B at a 15.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-27 | UBS | Buy (main) |
| 2026-07-22 | Wells Fargo | Equal-Weight (main) |
| 2026-07-22 | Mizuho | Neutral (main) |
| 2026-07-22 | Citigroup | Neutral (down) |
| 2026-07-13 | JP Morgan | Overweight (main) |
| 2026-07-10 | Evercore ISI Group | Outperform (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.036 |
| Retained earnings / assets | 0.473 |
| EBIT / assets | 0.106 |
| Equity / liabilities | 0.353 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MRSH | MARSH & MCLENNAN COMPANIES, INC. | 6/9 | 2.86 | 19.6 | +10.3% |
| AON | Aon plc | 6/9 | 1.13 | 19 | +9.4% |
| AJG | Arthur J. Gallagher & Co. | 5/9 | — | 38.9 | +20.7% |
| EQH | Equitable Holdings, Inc. | 4/9 | — | — | -6.1% |
| WTW | WILLIS TOWERS WATSON PLC | 6/9 | 1.51 | 15.3 | -2.2% |
| BRO | BROWN & BROWN, INC. | 3/9 | — | 20.7 | +22.8% |
| YB | Yuanbao Inc. | 4/9 | — | — | +33.1% |
All Finance, Insurance & Real Estate companies →
About MARSH & MCLENNAN COMPANIES, INC.
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions. It serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.
FAQ
Is MRSH financially healthy?
MARSH & MCLENNAN COMPANIES, INC.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MRSH pay a dividend, and is it safe?
Yes. MARSH & MCLENNAN COMPANIES, INC. pays a dividend yielding about 2.09% with a 40.8% payout ratio, rated “moderate” for safety.
How profitable is MRSH?
In FY2025, MARSH & MCLENNAN COMPANIES, INC. had a net margin of 15.4% and a return on equity of 27.2%.
Is MRSH overvalued or undervalued?
MARSH & MCLENNAN COMPANIES, INC. trades at about 22.4× trailing earnings — below its 10-year norm (10-year range 20.1×–32.8×, median 27.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MRSH?
The average Wall-Street price target for MARSH & MCLENNAN COMPANIES, INC. is $205.52, about 8.8% above the recent price, from 21 analysts (consensus: hold).
Is MRSH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MARSH & MCLENNAN COMPANIES, INC.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 19.6×, a dividend yield of 2.09%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.